Article Per Year (5 Year)
p-Index From 2021 - 2026
0.61
P-Index
This Author published in this journals
All Journal SENTRI: Jurnal Riset Ilmiah Jurnal Ilmiah Ekotrans & Erudisi (JIEE)
Minarsih, Tri Jenny
Unknown Affiliation
Aerospace Engineering Humanities Computer Science & IT Decision Sciences, Operations Research & Management Economics, Econometrics & Finance Environmental Science Law, Crime, Criminology & Criminal Justice Social Sciences

Published : 3 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 3 Documents
Search

 1 
Regulation of Drug Procurement and Supply Chain Management in Indonesian Hospitals: Implications for Drug Availability and Mitigation of Drug Shortage Arrasily, Nailul Fithri; Minarsih, Tri Jenny; Hartono, Budi; Daud, Alfani Ghutsa
Jurnal Ilmiah Ekotrans & Erudisi Vol. 5 No. 2 (2025): December 2025
Publisher : LPPM Universitas Ekasakti

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.69989/yg78vk12

Abstract

Pharmaceutical management in hospitals is a critical component of the healthcare system, directly influencing service quality and operational sustainability. This study examines the relationship between the pharmaceutical regulatory framework established by the Ministry of Health (Kemenkes) and the National Agency of Drug and Food Control (BPOM) and the operational performance of pharmaceutical Supply Chain Management (SCM) in Indonesian hospitals. A Systematic Literature Review (SLR) using a Scoping Review approach was conducted to synthesize quantitative evidence on drug procurement regulations, distribution, and inventory efficiency. Secondary data show that 34.7% of hospitals experience shortages of essential medicines at least once a year, and 80% of pharmaceutical distributors (PBFs) fail to meet the maximum three-day delivery lead time. This highlights a substantial gap between comprehensive regulations, such as Ministry of Health Regulation No. 17 of 2024 on Telepharmacy and BPOM Regulation No. 20 of 2025 on Good Distribution Practice (CDOB), and operational logistics implementation. The main challenge lies not in regulatory design but in weak enforcement of logistical discipline and supplier monitoring. Recommended strategies include performance-based contracts linking lead-time compliance to penalties or incentives and continuous data-driven training for pharmaceutical personnel. Strengthening the synergy between regulatory frameworks and operational discipline is essential to ensure sustainable drug availability and high-quality healthcare services in Indonesia.
Tinjauan Literatur: Model dan Mekanisme Distribusi Obat pada Instalasi Farmasi Rumah Sakit di Indonesia: Analisis Kuantitatif Kinerja dan Implikasi Keselamatan Pasien (2015–2025) Muharani, Defrika; Faizah, Hashifah; Arrasily, Nailul Fithri; Farhiyah, Nur Laili; Minarsih, Tri Jenny; Hartono, Budi; Daud, Alfani Ghutsa
SENTRI: Jurnal Riset Ilmiah Vol. 5 No. 1 (2026): SENTRI : Jurnal Riset Ilmiah, Januari 2026
Publisher : LPPM Institut Pendidikan Nusantara Global

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55681/sentri.v5i1.5378

Abstract

This literature review aims to synthesize quantitative empirical evidence from studies published between 2015 and 2025 concerning drug distribution models and logistic mechanisms implemented in Hospital Pharmacy Installations in Indonesia. The review focuses on comparing the effectiveness of the Unit Dose Dispensing system with conventional drug distribution models, namely Individual Prescribing and Floor Stock systems, while also examining the role of inventory control methods such as ABC-VEN Analysis and the Economic Order Quantity approach in improving pharmaceutical logistics performance. The findings reveal that national compliance of IFRS with established pharmaceutical care standards remains relatively low, reaching only 65.28%, indicating significant gaps in service quality and operational efficiency. Conventional distribution models are consistently associated with substantial inefficiencies, as reflected by an average inpatient drug return rate of approximately 18%, ranging from 17.11% to 19.62%. Prescription duplication emerges as the dominant contributor, accounting for 42.27% of total medication returns. Conversely, studies evaluating the implementation of the UDD system demonstrate a marked reduction in medication errors, highlighting its effectiveness in enhancing patient safety. From a financial perspective, the application of EOQ-based inventory management has shown the potential to reduce pharmaceutical inventory costs by an average of 8.21% per month, indicating meaningful improvements in cost efficiency. Overall, this review concludes that IFRS in Indonesia must progressively transition toward automated, standardized, and integrated drug distribution systems. Successful implementation requires addressing critical socio-technical challenges, including high initial investment costs, limitations in technological infrastructure, and resistance among healthcare personnel, to achieve optimal patient safety, and service quality.
Identifikasi dan Pengelolaan Risiko Pelayanan Farmasi di Rumah Sakit: Studi Deskriptif Muharani, Defrika; Arrasily, Nailul Fithry; Minarsih, Tri Jenny; Faizah, Hashifah; Farhiyah, Nur Laili; Hartono, Budi; Daud, Alfani Gusta
SENTRI: Jurnal Riset Ilmiah Vol. 5 No. 2 (2026): SENTRI : Jurnal Riset Ilmiah, Februari 2026
Publisher : LPPM Institut Pendidikan Nusantara Global

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55681/sentri.v5i2.5843

Abstract

Pharmacy services in hospitals are a vital component of healthcare systems, aiming to ensure the safe, rational, and efficient use of medicines. The increasing complexity of pharmacy operations elevates the likelihood of various risks in both clinical and operational domains. This study provides a descriptive analysis of the types of risks inherent in hospital pharmacy services and the corresponding risk management efforts based on empirical evidence. Findings reveal that medication errors are the most prevalent clinical risk, particularly during prescribing, preparation, and administration phases, potentially compromising patient safety and therapeutic outcomes. Operational risks also present significant challenges, as indicated by high levels of dead stock and expired medicines, reflecting weaknesses in forecasting and inventory control. Key contributing factors include limited human resources, suboptimal information systems, and high workload pressures. Additionally, barriers to incident reporting due to a punitive organizational culture hinder effective risk mitigation. Although the management of pharmaceutical risks is mandated by the Ministry of Health Regulation No. 72 of 2016, its implementation effectiveness remains constrained and demands improvement through integration of digital technologies, enhancement of pharmaceutical workforce competencies, and cultivation of a strong patient safety culture. These insights underscore the necessity for comprehensive strategies to foster pharmacy services that are safe, effective, and efficient.
Co-Authors Arrasily, Nailul Fithri Arrasily, Nailul Fithry Budi Hartono Daud, Alfani Ghutsa Daud, Alfani Gusta Faizah, Hashifah Farhiyah, Nur Laili muharani, Defrika